NAD+ vs NADH comes down to what the same molecule is carrying: electrons, tiny charged particles passed between chemical reactions. NAD+ is ready to accept them. NADH is carrying them and can hand them on. Both forms belong in normal cell chemistry.

That difference doesn't tell us whether an NAD+ injection works better than an NADH supplement. Understanding the molecule and choosing a treatment are separate questions.

NAD+ vs NADH: two forms of one carrier

NAD stands for nicotinamide adenine dinucleotide. It's a coenzyme, a helper molecule that enzymes need to carry out chemical reactions.

Picture a delivery carrier making repeated trips. NAD+ is the carrier ready to pick up a package. NADH has picked it up and can deliver it elsewhere. The package here is a pair of electrons carried with hydrogen. After handing it on, NADH becomes NAD+ again.

Oxidized describes NAD+, which can accept electrons. Reduced describes NADH, which has gained them. Oxidation means losing electrons; reduction means gaining them. Together, these exchanges are called redox reactions.

Question NAD+ NADH
Which form is it? Oxidized Reduced
What can it do? Accept electrons Donate the electrons it carries
What happens during the exchange? Becomes NADH Becomes NAD+

NADH isn't worn-out NAD+. Cells need both sides of the exchange. The plus sign doesn't mean a stronger product, either; it marks an electrical charge.

Older names can add confusion. Early yeast-fermentation papers called the helper coferment. The history of NAD traces those discoveries and the changing names. Its separate molecular identity guide explains why NAD belongs to a different chemical family from peptides.

What does the NAD/NADH ratio mean?

The NAD+/NADH ratio compares the amount of one form with the other in a specified sample. It isn't the same thing as the total amount of both forms.

For an arithmetic example, 10 units of NAD+ and one unit of NADH give a 10:1 ratio. So do 100 units and 10 units. The ratio is identical, but the total amount is ten times larger. These are examples, not healthy targets.

Location matters too. The cytosol, the fluid inside a cell but outside its internal structures, has a different chemical environment from mitochondria, the cell's energy-making structures. A 1967 rat-liver study in Biochemical Journal found their ratios differed and didn't always move together.

A number from blood therefore cannot stand in for every tissue or compartment. A higher ratio isn't automatically a better result, and a whole-body target can't be borrowed from one cell experiment.

What did the cell-sensor studies actually measure?

Researchers can build sensors into cells to follow these changes. A sensor turns a chemical change into a signal the laboratory can measure.

Zhao's 2016 Nature Protocols paper describes SoNar, a protein sensor whose light signal changes when it binds NAD+ or NADH. The work covers living cells and tumors grown in mice. It describes a measurement method rather than a treatment trial.

Huang's 2016 Journal of Biological Chemistry study used a different kind of sensor, also built from a bacterial protein, that switches a reporter gene on and off. It followed NADH-related changes in cultured human cells, including U2OS cells derived from a bone tumor. The signal rose and fell with the cells' daily clock.

These findings show that the balance can change with time and experimental conditions. They don't establish that a prescription normalizes a whole-body ratio. Cell-compartment measurements also don't establish superiority of NAD+ injections over NADH supplements.

Why a newer blood study matters

As of November 5, 2026, the day this article was written, a November 4 Nature Metabolism study adds an important measurement detail. Across 1,340 measurements in 1,068 adults, researchers measured total NAD, meaning NAD+ plus NADH, in dried blood spots. The original ratio changed as the blood dried, while the combined amount remained stable.

That distinction matters when a result is called an “NAD level.” Total NAD and the original ratio answer different questions. The study also found no age-related decline in total whole-blood NAD among healthy participants. It wasn't designed to show cause and effect or establish a benefit from supplementation.

Is NADH the same as an NAD+ injection?

An NADH supplement and an NAD+ injection contain different starting forms and enter the body differently. Their relationship inside cells doesn't make the products interchangeable. Chemistry alone can't establish how much reaches a particular tissue or whether someone feels better.

As of November 5, 2026, the day this article was written, a September 8 review in Frontiers in Nutrition provides human evidence about NAD-related supplements, including NADH. None showed a statistically significant improvement in reported tiredness, meaning the analysis couldn't clearly distinguish an effect from chance. On thinking tests, NADH showed the largest pooled improvement, mainly in people with cognitive impairment, but that result was sensitive to a few influential studies. The review did not compare NADH supplements with NAD+ injections.

For the separate question about ingredients the body uses to make NAD+, the NAD+ decision guide covers NR and NMN. Those names describe other molecules, rather than another spelling of NADH.

Preparation quality is a separate question

A molecule's natural role doesn't settle the quality of a particular preparation. FDA's ingredient-quality notice explains that food-grade NAD+ isn't suitable for injection without appropriate processing. Endotoxins, bacterial material that can trigger illness, are one concern.

As of November 5, 2026, the day this article was written, an FDA letter dated January 20, 2026 documents excessive endotoxins in a compounded NAD+ product after three patients developed reactions. This concerns a specific preparation; it doesn't rank NAD+ against NADH.

Compounded NAD+ is not FDA-approved. FDA explains that it doesn't verify compounded drugs' safety, effectiveness or quality before marketing. A licensed provider may still prescribe — that decision is between you and your doctor.

What makes the comparison useful at a visit?

A useful discussion starts with the goal: what symptom or daily task needs attention? It then connects that goal to evidence about the exact molecule, preparation and delivery method being considered.

A ratio result adds questions: what sample was tested, how was it handled, and what does that measurement establish? A follow-up plan needs a meaningful change for the person, rather than only a higher number.

The questions to ask before NAD+ cover that conversation. At Promise, a licensed provider reviews every request, and not everyone qualifies. When prescribed, compounded medication is prepared and dispensed by a licensed U.S. compounding pharmacy. The prescribing decision includes the evidence and the person's health history.